192 related articles for article (PubMed ID: 23334798)
41. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging.
Law M; Cha S; Knopp EA; Johnson G; Arnett J; Litt AW
Radiology; 2002 Mar; 222(3):715-21. PubMed ID: 11867790
[TBL] [Abstract][Full Text] [Related]
42. Discrimination between metastasis and glioblastoma multiforme based on morphometric analysis of MR images.
Blanchet L; Krooshof PW; Postma GJ; Idema AJ; Goraj B; Heerschap A; Buydens LM
AJNR Am J Neuroradiol; 2011 Jan; 32(1):67-73. PubMed ID: 21051512
[TBL] [Abstract][Full Text] [Related]
43. Computational quantitative MR image features - a potential useful tool in differentiating glioblastoma from solitary brain metastasis.
Petrujkić K; Milošević N; Rajković N; Stanisavljević D; Gavrilović S; Dželebdžić D; Ilić R; Di Ieva A; Maksimović R
Eur J Radiol; 2019 Oct; 119():108634. PubMed ID: 31473463
[TBL] [Abstract][Full Text] [Related]
44. Quantitative combination of volumetric MR imaging and MR spectroscopy data for the discrimination of meningiomas from metastatic brain tumors by means of pattern recognition.
Georgiadis P; Kostopoulos S; Cavouras D; Glotsos D; Kalatzis I; Sifaki K; Malamas M; Solomou E; Nikiforidis G
Magn Reson Imaging; 2011 May; 29(4):525-35. PubMed ID: 21315534
[TBL] [Abstract][Full Text] [Related]
45. Analysis of brain tumors using 1H magnetic resonance spectroscopy.
McBride DQ; Miller BL; Nikas DL; Buchthal S; Chang L; Chiang F; Booth RA
Surg Neurol; 1995 Aug; 44(2):137-44. PubMed ID: 7502203
[TBL] [Abstract][Full Text] [Related]
46. Supervised pattern recognition for the prediction of contrast-enhancement appearance in brain tumors from multivariate magnetic resonance imaging and spectroscopy.
Lee MC; Nelson SJ
Artif Intell Med; 2008 May; 43(1):61-74. PubMed ID: 18448318
[TBL] [Abstract][Full Text] [Related]
47. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.
Law M; Yang S; Wang H; Babb JS; Johnson G; Cha S; Knopp EA; Zagzag D
AJNR Am J Neuroradiol; 2003; 24(10):1989-98. PubMed ID: 14625221
[TBL] [Abstract][Full Text] [Related]
48. Differentiation of hemangioblastomas from pilocytic astrocytomas using 3-T magnetic resonance perfusion-weighted imaging and MR spectroscopy.
She DJ; Xing Z; Zeng Z; Shang XY; Cao DR
Neuroradiology; 2015 Mar; 57(3):275-81. PubMed ID: 25487356
[TBL] [Abstract][Full Text] [Related]
49. Automated classification of neurological disorders of gait using spatio-temporal gait parameters.
Pradhan C; Wuehr M; Akrami F; Neuhaeusser M; Huth S; Brandt T; Jahn K; Schniepp R
J Electromyogr Kinesiol; 2015 Apr; 25(2):413-22. PubMed ID: 25725811
[TBL] [Abstract][Full Text] [Related]
50. Can proton MR spectroscopic and perfusion imaging differentiate between neoplastic and nonneoplastic brain lesions in adults?
Hourani R; Brant LJ; Rizk T; Weingart JD; Barker PB; Horská A
AJNR Am J Neuroradiol; 2008 Feb; 29(2):366-72. PubMed ID: 18055564
[TBL] [Abstract][Full Text] [Related]
51. Quantitative short echo time 1H MRSI of the peripheral edematous region of human brain tumors in the differentiation between glioblastoma, metastasis, and meningioma.
Wijnen JP; Idema AJ; Stawicki M; Lagemaat MW; Wesseling P; Wright AJ; Scheenen TW; Heerschap A
J Magn Reson Imaging; 2012 Nov; 36(5):1072-82. PubMed ID: 22745032
[TBL] [Abstract][Full Text] [Related]
52. Diagnostic utility of diffusion tensor imaging in differentiating glioblastomas from brain metastases.
Wang S; Kim SJ; Poptani H; Woo JH; Mohan S; Jin R; Voluck MR; O'Rourke DM; Wolf RL; Melhem ER; Kim S
AJNR Am J Neuroradiol; 2014 May; 35(5):928-34. PubMed ID: 24503556
[TBL] [Abstract][Full Text] [Related]
53. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
Fayed N; Dávila J; Medrano J; Olmos S
Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
[TBL] [Abstract][Full Text] [Related]
54. Differentiation of glioblastoma multiforme and single brain metastasis by peak height and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.
Cha S; Lupo JM; Chen MH; Lamborn KR; McDermott MW; Berger MS; Nelson SJ; Dillon WP
AJNR Am J Neuroradiol; 2007; 28(6):1078-84. PubMed ID: 17569962
[TBL] [Abstract][Full Text] [Related]
55. Differentiation of metastases from high-grade gliomas using short echo time 1H spectroscopy.
Opstad KS; Murphy MM; Wilkins PR; Bell BA; Griffiths JR; Howe FA
J Magn Reson Imaging; 2004 Aug; 20(2):187-92. PubMed ID: 15269942
[TBL] [Abstract][Full Text] [Related]
56. Machine learning methods for the classification of gliomas: Initial results using features extracted from MR spectroscopy.
Ranjith G; Parvathy R; Vikas V; Chandrasekharan K; Nair S
Neuroradiol J; 2015 Apr; 28(2):106-11. PubMed ID: 25923676
[TBL] [Abstract][Full Text] [Related]
57. Spectroscopic, diffusion and perfusion magnetic resonance imaging at 3.0 Tesla in the delineation of glioblastomas: preliminary results.
Di Costanzo A; Trojsi F; Giannatempo GM; Vuolo L; Popolizio T; Catapano D; Bonavita S; d'Angelo VA; Tedeschi G; Scarabino T
J Exp Clin Cancer Res; 2006 Sep; 25(3):383-90. PubMed ID: 17167979
[TBL] [Abstract][Full Text] [Related]
58. Primary and metastatic intraaxial brain tumors: prospective comparison of multivoxel 2D chemical-shift imaging (CSI) proton MR spectroscopy, perfusion MRI, and histopathological findings in a group of 159 patients.
Bendini M; Marton E; Feletti A; Rossi S; Curtolo S; Inches I; Ronzon M; Longatti P; Di Paola F
Acta Neurochir (Wien); 2011 Feb; 153(2):403-12. PubMed ID: 21165751
[TBL] [Abstract][Full Text] [Related]
59. In vivo single-voxel proton MR spectroscopy in the differentiation of high-grade gliomas and solitary metastases.
Fan G; Sun B; Wu Z; Guo Q; Guo Y
Clin Radiol; 2004 Jan; 59(1):77-85. PubMed ID: 14697379
[TBL] [Abstract][Full Text] [Related]
60. The use of proton MRS in the differential diagnosis of brain tumors and tumor-like processes.
Gajewicz W; Papierz W; Szymczak W; Goraj B
Med Sci Monit; 2003 Sep; 9(9):MT97-105. PubMed ID: 12960934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
